|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | A61K 45/00 | (2006.01) |
| A61K | (2006.01) | ||
| A61K 9/10 | (2006.01) | ||
| A61K 9/16 | (2006.01) | ||
| A61K 9/22 | (2006.01) | ||
| A61K 9/26 | (2006.01) | ||
| A61K 9/50 | (2006.01) | ||
| A61K 9/52 | (2006.01) | ||
| A61K 9/54 | (2006.01) | ||
| A61K 31/135 | (2006.01) | ||
| A61K 31/137 | (2006.01) | ||
| A61P 1/00 | (2006.01) | ||
| A61P 13/00 | (2006.01) | ||
| A61P 13/10 | (2006.01) |
| (11) | Number of the document | 1227806 |
| (13) | Kind of document | T |
| (96) | European patent application number | 00975092.8 |
| Date of filing the European patent application | 2000-10-24 | |
| (97) | Date of publication of the European application | 2002-08-07 |
| (45) | Date of publication and mention of the grant of the patent | 2005-08-03 |
| (46) | Date of publication of the claims translation | 2005-11-25 |
| (86) | Number | PCT/SE2000/002061 |
| Date | 2000-10-24 |
| (87) | Number | WO 2001/034139 |
| Date | 2001-05-17 |
| (30) | Number | Date | Country code |
| PCT/SE99/02052 | 1999-11-11 | WO | |
| 0000782 | 2000-03-09 | SE |
| (72) |
NILVEBRANT, Lisbeth, SE
HALLEN, Bengt, SE
OLSSON, Birgitta, SE
STRÖMBOM, Jan, SE
GREN, Torkel, US
RINGBERG, Anders, SE
WIKBERG, Martin, SE
|
| (73) |
Pfizer Health AB,
112 87 Stockholm,
SE
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Farmacinė vaisto forma, turinti tolterodiną ir jos panaudojimas |
| PHARMACEUTICAL FORMULATION CONTAINING TOLTERODINE AND ITS USE |
| Payment date | Validity (years) | Amount | |
| 2008-09-26 | 9 | 720.00 LTL |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2009-03-02 |